Bellevue Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.3M | Buy |
|
|||||
|
2025
Q1 | $55.7M | Hold |
|
|||||
|
2024
Q4 | $77.6M | Hold |
|
|||||
|
2024
Q3 | $104M | Buy |
|
|||||
|
2024
Q2 | $110M | Buy |
|
|||||
|
2024
Q1 | $117M | Buy |
|
|||||
|
2023
Q4 | $95.8M | Buy |
|
|||||
|
2023
Q3 | $52.3M | Buy |
|
|||||
|
2023
Q2 | $61.1M | Hold |
|
|||||
|
2023
Q1 | $64.8M | Hold |
|
|||||
|
2022
Q4 | $80.2M | Hold |
|
|||||
|
2022
Q3 | $50.6M | Buy |
|
|||||
|
2022
Q2 | $24.9M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $458K | Hold |
|
|||||
|
2017
Q2 | $395K | Hold |
|
|||||
|
2017
Q1 | $578K | Hold |
|
|||||
|
2016
Q4 | $566K | Hold |
|
|||||
|
2016
Q3 | $646K | Hold |
|
|||||
|
2016
Q2 | $702K | Hold |
|
|||||
|
2016
Q1 | $605K | Buy |
|